Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical Lymphoma, Myeloma & Leukemia|July 31, 2020
Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on RuxolitinibFrancine M Foss, Ami Rubinowitz, Marie L Landry, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 10, 2019
The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN)Sarah Perreault, Dayna McManus, Noffar Bar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 2, 2016
Autologous Stem Cell Mobilization in the Age of PlerixaforDennis L Cooper, Erin Medoff, Natalie Patel, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 22, 2021
Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusionSarah Perreault, Molly Schiffer, Virginia Clinchy-Jarmoszko, et al.
Leukemia & Lymphoma|December 16, 2020
High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasisJennifer Zhao, Jan Philipp Bewersdorf, Sara Jaszczur, et al.
Blood Advances|April 25, 2018
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohortMaximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2018
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective StudyMaximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
Pageof 2